Home » Topics » BioWorld Science, Conferences

BioWorld Science, Conferences
RSS

YM-872 shows potential for stroke in animal models

Aug. 13, 1997

Antiischemic activity of calmodulin antagonist reported

Aug. 13, 1997

NR2B-selective NMDA antagonist for occlusive stroke

Aug. 13, 1997

Bradykinin antagonist shows potential in stroke and ischemic disorders

Aug. 13, 1997

YM90K efficacy shown in rat model of cerebral ischemia

Aug. 13, 1997

Endothelin antagonists for cerebral ischemia

Aug. 13, 1997

P&U antioxidant shows cerebroprotective activity in rats

Aug. 13, 1997

Metabolic studies on sameridine described at ISSX meeting

Aug. 11, 1997

Metabolism of antidepressant studied in vivo

Aug. 11, 1997

Oral bioavailability of palinavir studied in various animal models

Aug. 11, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 26, 2026.
ENCALS 2026: From genetics to advancing strategies against ALS
BioWorld Science
Amyotrophic lateral sclerosis (ALS)-associated genes provide direct therapeutic targets and reveal pathways that can be used to develop treatments that counteract...
Next wave of BCI firms builds on pioneers to tackle challenges
BioWorld
With the pace of neurotechnology development accelerating, a wave of brain-computer interface (BCI) companies is emerging on the heels of the pioneers. In the...
Boehringer Ingelheim identifies new mGlu3 receptor agonists
BioWorld Science
Boehringer Ingelheim Pharma GmbH & Co. KG and Vanderbilt University have discovered new dihydrobenzoxazine compounds acting as metabotropic glutamate mGlu3...
GT-02897 exerts efficacy in preclinical multiple myeloma
BioWorld Science
Investigators from the Karl Landsteiner University aimed to evaluate the therapeutic potential of a novel CDK9 inhibitor/degrader, GT-02897, for the potential...